AR246012A1 - Metodo para producir tabletas de colestiramina directamente comprimidas que poseen un revestimiento libre de solventes. - Google Patents

Metodo para producir tabletas de colestiramina directamente comprimidas que poseen un revestimiento libre de solventes.

Info

Publication number
AR246012A1
AR246012A1 AR90316365A AR31636590A AR246012A1 AR 246012 A1 AR246012 A1 AR 246012A1 AR 90316365 A AR90316365 A AR 90316365A AR 31636590 A AR31636590 A AR 31636590A AR 246012 A1 AR246012 A1 AR 246012A1
Authority
AR
Argentina
Prior art keywords
solvent
direct compression
free coating
coating therefor
cholestyramine
Prior art date
Application number
AR90316365A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of AR246012A1 publication Critical patent/AR246012A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Abstract

UN METODO PARA PRODUCIR TABLETAS DE COLESTIRAMINA QUE COMPRENDE: A) FORMAR UNA COMPOSICION EN TABLETAS DE UNA MEZCLA DE COLESTIRAMINA Y HASTA 0,3% P/P DE ESTEARATO DE MG. B) RECUBRIR POR ASPERSION LAS TABLETAS FORMADAS CON UN RECUBRIMIENTO QUE COMPRENDE 60-95% P/P DE ACIDO ESTEARICO Y 5-40% P/P DE POLIETILENGLICOL DE PESO MOLECULAR COMPRENDIDO ENTRE 3015-9685 Y 10 A 20% P/P DE ACEITES VEGETALES HIDROGENADOS.
AR90316365A 1989-03-16 1990-03-13 Metodo para producir tabletas de colestiramina directamente comprimidas que poseen un revestimiento libre de solventes. AR246012A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/324,167 US4956182A (en) 1989-03-16 1989-03-16 Direct compression cholestyramine tablet and solvent-free coating therefor

Publications (1)

Publication Number Publication Date
AR246012A1 true AR246012A1 (es) 1994-03-30

Family

ID=23262387

Family Applications (1)

Application Number Title Priority Date Filing Date
AR90316365A AR246012A1 (es) 1989-03-16 1990-03-13 Metodo para producir tabletas de colestiramina directamente comprimidas que poseen un revestimiento libre de solventes.

Country Status (34)

Country Link
US (1) US4956182A (es)
EP (1) EP0387885B1 (es)
JP (1) JP2974719B2 (es)
KR (1) KR0140211B1 (es)
CN (1) CN1047935C (es)
AR (1) AR246012A1 (es)
AT (1) ATE128031T1 (es)
AU (1) AU617601B2 (es)
BG (1) BG60501B1 (es)
CA (1) CA2012300A1 (es)
CS (1) CS277488B6 (es)
CY (1) CY1899A (es)
DD (1) DD292837A5 (es)
DE (1) DE69022452T2 (es)
DK (1) DK0387885T3 (es)
EG (1) EG19669A (es)
ES (1) ES2078917T3 (es)
FI (1) FI92464C (es)
GR (1) GR3017460T3 (es)
HK (1) HK51396A (es)
HU (1) HU209958B (es)
IE (1) IE70591B1 (es)
IL (1) IL93720A0 (es)
MY (1) MY109744A (es)
NO (1) NO176043C (es)
NZ (1) NZ232864A (es)
OA (1) OA09198A (es)
PL (1) PL163301B1 (es)
PT (1) PT93452B (es)
RO (1) RO106953B1 (es)
RU (1) RU2069558C1 (es)
YU (1) YU52390A (es)
ZA (1) ZA902001B (es)
ZW (1) ZW1890A1 (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5372823A (en) * 1989-03-16 1994-12-13 Bristol-Myers Squibb Company Direct compression cholestyramine tablet and solvent-free coating thereof
US5262167A (en) * 1990-12-20 1993-11-16 Basf Corporation Edible, non-baked low moisture cholestyramine composition
CA2129079C (en) * 1993-08-03 2006-01-17 Tatsuo Nomura Orally administrable cholesterol lowering agent
DE69530308T2 (de) * 1994-09-22 2003-10-16 Akzo Nobel Nv Verfahren zur herstellung von dosierungsformen durch feuchtgranulierung
TW592727B (en) * 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
WO2000025752A1 (en) 1998-11-02 2000-05-11 Church, Marla, J. Multiparticulate modified release composition
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
US20020054903A1 (en) * 1999-10-19 2002-05-09 Joseph Tyler Direct compression polymer tablet core
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
CN102716101A (zh) 1999-10-29 2012-10-10 欧罗赛铁克股份有限公司 控释氢可酮制剂
EP2283829A1 (en) 2000-10-30 2011-02-16 Euro-Celtique S.A. Controlled release hydrocodone formulations
CN1491105A (zh) * 2001-02-13 2004-04-21 新的改进释放的制剂
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
JP2005529059A (ja) 2001-09-28 2005-09-29 マクニール−ピーピーシー・インコーポレイテッド 改質した放出用の投薬形態
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US6982094B2 (en) 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US7807197B2 (en) 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
ES2400186T3 (es) * 2004-05-24 2013-04-08 Mepha Schweiz Ag Procedimiento para recubrimiento en seco
EP1811957B1 (en) * 2004-10-19 2008-11-26 KRKA, tovarna zdravil, d.d., Novo mesto Solid pharmaceutical composition comprising donepezil hydrochloride
US20060177415A1 (en) * 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
EP1951266A2 (en) 2005-09-02 2008-08-06 Genzyme Corporation Method for removing phosphate and polymer used therefore
JP5595660B2 (ja) 2005-09-15 2014-09-24 ジェンザイム コーポレーション アミンポリマー用サシェ製剤
DE102005060377A1 (de) * 2005-12-16 2007-06-21 Ratiopharm Gmbh Pharmazeutische Zusammensetzung enthaltend Donepezilhydrochlorid, Tablette hieraus und Verfahren zu deren Herstellung
US20090252794A1 (en) 2006-08-09 2009-10-08 Tetsuya Suzuki Tablet
US8425887B2 (en) 2006-09-29 2013-04-23 Genzyme Corporation Amide dendrimer compositions
WO2008076242A1 (en) 2006-12-14 2008-06-26 Genzyme Corporation Amido-amine polymer compositions
JP6067100B2 (ja) 2012-04-18 2017-01-25 マリンクロッド エルエルシー 即放性乱用抑止医薬組成物
JP5469286B1 (ja) 2013-10-25 2014-04-16 株式会社クラレ 複層フィルム及びそれからなる合わせガラス用中間膜
WO2016004170A1 (en) 2014-07-03 2016-01-07 Mallinckrodt Llc Abuse deterrent immediate release formulations comprising non-cellulose polysaccharides
EP3413875B1 (en) * 2016-02-09 2020-01-29 Albireo AB Cholestyramine pellets and methods for preparation thereof
ES2874669T3 (es) * 2016-02-09 2021-11-05 Albireo Ab Formulación oral de colestiramina y uso de la misma
WO2020068510A1 (en) 2018-09-25 2020-04-02 SpecGx LLC Abuse deterrent immediate release capsule dosage forms
CN114053234A (zh) * 2021-12-29 2022-02-18 江苏省药物研究所有限公司 一种阿卡波糖片及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB595444A (en) * 1945-07-09 1947-12-04 Gwilym Lloyd Thomas Improvements in or relating to medicaments, and to the preparation thereof
US3383237A (en) * 1964-01-29 1968-05-14 Richardson Merrell Inc Tablet coating
JPS56140915A (en) * 1980-04-07 1981-11-04 Yamanouchi Pharmaceut Co Ltd Pharmaceutical preparation for solid drug
US4895723A (en) * 1986-09-08 1990-01-23 Amer And Company Cholestyramine compositions and method for preparation thereof
ZA876640B (en) * 1986-09-26 1988-03-08 Warner-Lambert Company Treated lipid regulator
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale

Also Published As

Publication number Publication date
OA09198A (fr) 1992-06-30
HK51396A (en) 1996-03-29
KR900013946A (ko) 1990-10-22
PT93452B (pt) 1996-12-31
HU901429D0 (en) 1990-06-28
DD292837A5 (de) 1991-08-14
NO901183L (no) 1990-09-17
FI92464B (fi) 1994-08-15
NO901183D0 (no) 1990-03-14
PL163301B1 (en) 1994-03-31
EP0387885A3 (en) 1992-06-17
EG19669A (en) 1995-08-30
HU209958B (en) 1994-12-28
ES2078917T3 (es) 1996-01-01
NO176043B (no) 1994-10-17
NZ232864A (en) 1992-04-28
CS277488B6 (en) 1993-03-17
JP2974719B2 (ja) 1999-11-10
KR0140211B1 (ko) 1998-06-01
DE69022452T2 (de) 1996-03-14
RO106953B1 (ro) 1993-08-30
US4956182A (en) 1990-09-11
CY1899A (en) 1990-03-15
IL93720A0 (en) 1990-12-23
RU2069558C1 (ru) 1996-11-27
MY109744A (en) 1997-05-31
CN1047935C (zh) 2000-01-05
BG60501B1 (bg) 1995-06-30
FI92464C (fi) 1994-11-25
AU617601B2 (en) 1991-11-28
JPH03236326A (ja) 1991-10-22
HUT54489A (en) 1991-03-28
IE900941L (en) 1990-09-16
DK0387885T3 (da) 1995-11-06
DE69022452D1 (de) 1995-10-26
IE70591B1 (en) 1996-12-11
EP0387885A2 (en) 1990-09-19
EP0387885B1 (en) 1995-09-20
NO176043C (no) 1995-01-25
GR3017460T3 (en) 1995-12-31
CA2012300A1 (en) 1990-09-16
AU5136790A (en) 1990-09-20
FI901241A0 (fi) 1990-03-13
ZA902001B (en) 1990-11-28
CN1045921A (zh) 1990-10-10
YU52390A (en) 1991-10-31
ATE128031T1 (de) 1995-10-15
PT93452A (pt) 1990-11-07
ZW1890A1 (en) 1990-10-31

Similar Documents

Publication Publication Date Title
AR246012A1 (es) Metodo para producir tabletas de colestiramina directamente comprimidas que poseen un revestimiento libre de solventes.
ES2152966T3 (es) Formas de dosificado farmaceuticas de desleido rapido y procedimiento para su preparacion.
UA39174C2 (uk) Асоціати депротонованої гіалуронової кислоти, спосіб одержання асоціатів депротонованої гіалуронової кислоти, фармацевтична композиція та спосіб одержання фармацевтичної композиції
IL128672A0 (en) A process for the production of solid pharmaceutical forms
ES2058799T3 (es) Composiciones estabilizadas que contienen factor de crecimiento epidermico.
ES2155923T3 (es) Procedimiento para preparar composiciones utiles como intermediarios para la preparacion de aditivos para aceites lubricantes y combustibles.
IT1174791B (it) Composizioni farmaceutiche a base di inf.alcanoli applicabili per via topica e procedimento per la loro produzione ed impiego
FI872731A0 (fi) Purukumikantaja ja menetelmä aktiiviainetta sisältävän purukumin valmistamiseksi
AR022008A1 (es) Una composicion de liberacion controlada de galantamina, un proceso para la preparacion de la misma, y el uso de dicha composicion para la preparacion de un medicamento
EP0151344A3 (en) A chewing gum composition, a process for preparing a chewing gum tablet therefrom, and a chewing gum tablet
HK1024865A1 (en) Pharmaceutical compositions comprising a mixture of autocross-linked hyaluronic acid and nonautocross-linked hyaluronic acid and their use for the treatment of arthropathies
KR840005661A (ko) 지속성 매트릭스 정제 조성물의 제조방법
ES2026198T3 (es) Compuesto a base de acido valproico solido, estable a la humedad y metodo para su preparacion.
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
HUT34350A (en) Prcess for production of partable pills with deferred decreasing of the reagents
AR022358A1 (es) Una composicion de epo, un procedimiento para su obtencion, un preparado farmaceutico que la contiene y un procedimiento para aumentar la actividadespecifica de una composicion de epo
ES2110212T3 (es) Composicion farmaceutica efervescente que contiene ibuprofeno y su procedimiento de preparacion.
ES8605956A1 (es) Procedimiento para preparar una composicion antiacido
UA19782A (uk) Спосіб одержаhhя біциклічhих складhих ефірів або їх фармацевтичhо прийhятhих солей
ES2061688T3 (es) Composiciones farmaceuticas que comprenden una calcitonina y un glicirricinato como mejorador de la absorcion.
DE3884214T2 (de) Verfahren zur herstellung einer festen form mit beibehaltender freisetzung aus einer funktionellen aktiven komposition und die bei dem verfahren erhaltene dosierungsform.
HK1030604A1 (en) Method for the synthesis of huperzine a and analogs thereof and compounds useful therein
AU7335696A (en) Water-soluble vitamin composition that provides excellent tablets and process for producing the same
ES2030013T3 (es) Procedimiento para producir un nuevo compuesto que tiene base de hipoxantina.
DE69311541D1 (de) Kosmetische oder pharmazeutische zusammensetzungen zur topischen anwendung die deacylierten glycerophospholipide enthalten